Alto, a digital pharmacy and drug delivery company, will announce next week the close of a $250 million Series D funding round headed by SoftBank’s Vision Fund 2, Reuters and others reported this morning. Greenoaks Capital, Jackson Square Ventures and other prior backers also participated in the round.
This round would bring Alto’s total raise to more than $350 million, and its valuation to more...
Direct-to-consumer telemedicine services have attracted plenty of attention from investors and patients alike, due in part to their lower costs and ease of use. From a medical standpoint, however, these business models introduce a number of departures from traditional care that deserve serious concern and investigation, argue the authors of an editorial published Friday in JAMA.
“DTC telemedicine...
